Literature DB >> 17468514

Carcinogen-induced histone alteration in normal human mammary epithelial cells.

Chastity Bradley1, Riet van der Meer, Nady Roodi, Heping Yan, Mahesh B Chandrasekharan, Zu-Wen Sun, Ray L Mernaugh, Fritz F Parl.   

Abstract

Little is known about early carcinogen-induced protein alterations in mammary epithelium. Detection of early alterations would enhance our understanding of early-stage carcinogenesis. Here, normal human mammary epithelial cells (HMECs) were exposed to dietary and environmental carcinogens [2-amino-1-methyl-6-phenylimidazo[4,5b]pyridine (PhIP), 4-aminobiphenyl (ABP), benzo[a]pyrene, 2,3,7,8-tetrachlorodibenzo-p-dioxin] individually or in combination. A phage display library of single-chain variable fragment antibodies was used to screen protein targets altered by the treatment. In combination with matrix-assisted laser desorption time of flight, we identified histone H3 as a target antigen. Although histone H3 total protein remained unchanged in control and treated HMEC, the methylation of lysine 4 was altered. A reduction in mono-methyl histone H3 (Lys 4) was observed in treated HMEC compared with control HMEC. This alteration was shown to be dependent on carcinogen concentration and specific for PhIP and ABP. To characterize potential histone demethylation mechanisms, localization and protein expression patterns of lysine-specific demethylase 1 (LSD1) were analyzed. In control HMEC, LSD1 was present at the nuclear periphery. However, following 72 h carcinogen treatment, LSD1 localized within the nucleus. Within 48 h after treatment, mono-methyl histone H3 (Lys 4) was restored and LSD1 localization was reversed. Protein expression levels of LSD1 were also increased in treated HMEC compared with control HMEC. Our data suggest that the induction of a single enzyme, LSD1, represents an early response to carcinogen exposure, which leads to the demethylation of histone H3 (Lys 4), which, in turn, may influence the expression of multiple genes critical in early-stage mammary carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17468514     DOI: 10.1093/carcin/bgm100

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  22 in total

Review 1.  Epigenetic reprogramming and imprinting in origins of disease.

Authors:  Wan-yee Tang; Shuk-mei Ho
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

Review 2.  Phosphorylation of epigenetic "readers, writers and erasers": Implications for developmental reprogramming and the epigenetic basis for health and disease.

Authors:  Lindsey S Treviño; Quan Wang; Cheryl L Walker
Journal:  Prog Biophys Mol Biol       Date:  2015-04-02       Impact factor: 3.667

Review 3.  Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review.

Authors:  Grace Chappell; Igor P Pogribny; Kathryn Z Guyton; Ivan Rusyn
Journal:  Mutat Res Rev Mutat Res       Date:  2016-03-31       Impact factor: 5.657

4.  Characterization of the native and denatured herceptin by enzyme linked immunosorbent assay and quartz crystal microbalance using a high-affinity single chain fragment variable recombinant antibody.

Authors:  Yuqin Shang; Ray Mernaugh; Xiangqun Zeng
Journal:  Anal Chem       Date:  2012-09-13       Impact factor: 6.986

5.  Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells.

Authors:  Yi Huang; Shauna N Vasilatos; Lamia Boric; Patrick G Shaw; Nancy E Davidson
Journal:  Breast Cancer Res Treat       Date:  2011-03-31       Impact factor: 4.872

6.  Reactivation of L1 retrotransposon by benzo(a)pyrene involves complex genetic and epigenetic regulation.

Authors:  Ivo Teneng; Diego E Montoya-Durango; James L Quertermous; Mary E Lacy; Kenneth S Ramos
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

7.  Thermodynamic characterization of the binding interaction between the histone demethylase LSD1/KDM1 and CoREST.

Authors:  Sunhee Hwang; Allison A Schmitt; Andrea E Luteran; Eric J Toone; Dewey G McCafferty
Journal:  Biochemistry       Date:  2010-12-30       Impact factor: 3.162

Review 8.  Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

Authors:  Xuejiao Tian; Saiyang Zhang; Hong-Min Liu; Yan-Bing Zhang; Christopher A Blair; Dan Mercola; Paolo Sassone-Corsi; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2013-06       Impact factor: 3.428

Review 9.  Polyamine analogues targeting epigenetic gene regulation.

Authors:  Yi Huang; Laurence J Marton; Patrick M Woster; Robert A Casero
Journal:  Essays Biochem       Date:  2009-11-04       Impact factor: 8.000

10.  Targeted multiplex imaging mass spectrometry with single chain fragment variable (scfv) recombinant antibodies.

Authors:  Gwendoline Thiery; Ray L Mernaugh; Heping Yan; Jeffrey M Spraggins; Junhai Yang; Fritz F Parl; Richard M Caprioli
Journal:  J Am Soc Mass Spectrom       Date:  2012-08-07       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.